Free Trial
NASDAQ:INCR

InterCure (INCR) Stock Price, News & Analysis

InterCure logo
$1.42 +0.02 (+1.06%)
As of 10:58 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About InterCure Stock (NASDAQ:INCR)

Key Stats

Today's Range
$1.39
$1.42
50-Day Range
$1.40
$1.75
52-Week Range
$1.17
$3.72
Volume
3,864 shs
Average Volume
37,393 shs
Market Capitalization
$64.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Remove Ads

InterCure Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
16th Percentile Overall Score

INCR MarketRank™: 

InterCure scored higher than 16% of companies evaluated by MarketBeat, and ranked 888th out of 935 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for InterCure.

  • Percentage of Shares Shorted

    0.10% of the float of InterCure has been sold short.
  • Short Interest Ratio / Days to Cover

    InterCure has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InterCure has recently decreased by 1.79%, indicating that investor sentiment is improving.
  • Dividend Yield

    InterCure does not currently pay a dividend.

  • Dividend Growth

    InterCure does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.10% of the float of InterCure has been sold short.
  • Short Interest Ratio / Days to Cover

    InterCure has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InterCure has recently decreased by 1.79%, indicating that investor sentiment is improving.
  • News Sentiment

    InterCure has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.82 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for InterCure this week, compared to 0 articles on an average week.
  • MarketBeat Follows

    Only 1 people have added InterCure to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, InterCure insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.24% of the stock of InterCure is held by insiders.

  • Percentage Held by Institutions

    Only 8.34% of the stock of InterCure is held by institutions.

  • Read more about InterCure's insider trading history.
Receive INCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InterCure and its competitors with MarketBeat's FREE daily newsletter.

INCR Stock News Headlines

InterCure names Alexander Rabinovich as Chairman, replacing Ehud Barak
Musk’s real agenda in D.C.
In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…
InterCure Secures Major Funding to Boost Growth
Rising High: Exclusive talk with house of brands Carma HoldCo
InterCure Ltd. (INCR)
See More Headlines

INCR Stock Analysis - Frequently Asked Questions

InterCure's stock was trading at $1.59 at the beginning of 2025. Since then, INCR shares have decreased by 10.4% and is now trading at $1.4250.
View the best growth stocks for 2025 here
.

InterCure's top institutional shareholders include Moore Capital Management LP (0.21%), Citadel Advisors LLC and Concourse Financial Group Securities Inc..

Shares of INCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that InterCure investors own include NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), Advanced Micro Devices (AMD), Tesla (TSLA), Innovative Industrial Properties (IIPR) and AbbVie (ABBV).

Company Calendar

Today
3/31/2025
Next Earnings (Estimated)
5/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:INCR
Fax
N/A
Employees
350
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$272.67 million
Price / Cash Flow
N/A
Book Value
$2.72 per share
Price / Book
0.52

Miscellaneous

Free Float
45,464,000
Market Cap
$64.26 million
Optionable
Optionable
Beta
1.28
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:INCR) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners